Indocyanine green versus technetium-99m for sentinel lymph node biopsy in breast cancer: the FLUORO trial - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/41092412/
ICG fluorescence performed similarly to 99mTc lymphoscintigraphy and may be less costly over the long term.
In this prospective FLUORO trial of 305 patients, indocyanine green fluorescence achieved sentinel lymph node detection rates comparable to technetium-99m, offering similar efficacy, reduced radiation exposure, and potential long-term cost advantages in breast cancer surgery.
The effect of Citrus aurantium inhalation aromatherapy on chemotherapy-induced nausea and vomiting in breast cancer patients: a randomized controlled trial - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/41057867/
This trial was registered with the Iranian Registry of Clinical Trials (IRCT20240305061177N1, march 17, 2024).
This randomized controlled trial found that Citrus aurantium inhalation aromatherapy significantly reduced delayed-phase chemotherapy-induced nausea and vomiting in breast cancer patients, suggesting an effective, low-cost, complementary approach alongside standard antiemetic therapy.
Radiation Risk in 2D Mammography Screening: A Scoping Review of Modelling Strategies and Emerging AI Applications - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/41044796/
Breast cancer is the most commonly diagnosed cancer among women worldwide, and concerns regarding radiation exposure from mammography screening remain a potential barrier to participation. This scoping review explores existing...
This review examines radiation risk modeling in 2D mammography, highlighting dose variability, influencing factors, and AI-driven strategies to optimize individualized risk assessment and enhance safety in breast cancer screening programs.
Breast cancer: pathogenesis and treatments - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39966355/
Breast cancer, characterized by unique epidemiological patterns and significant heterogeneity, remains one of the leading causes of malignancy-related deaths in women. The increasingly nuanced molecular subtypes of breast cancer have...
Breast cancer research advances highlight molecular subtyping, tumor biology, AI-driven diagnostics, and emerging personalized therapies, supporting precision oncology and improved long-term patient management.
ESR Essentials: screening for breast cancer - general recommendations by EUSOBI - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38656711/
Breast cancer is the most frequently diagnosed cancer in women accounting for about 30% of all new cancer cases and the incidence is constantly increasing. Implementation of mammographic screening has...
Breast cancer screening reduces mortality but faces challenges of underdiagnosis and overdiagnosis. Emerging strategies include supplemental imaging, AI support, and risk-stratified personalized screening, particularly for high-risk and dense-breasted women.